{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-115930","form_type":"8-K","ticker":"QTRX","cik":"0001503274","company_name":"Quanterix Corp","filed_at":"2022-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.892765+00:00","generated_at":"2026-06-22T03:28:19.536435+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Quanterix Q3 net loss $35.1M; takes $20.6M in impairment and restructuring charges","bullets":["Revenue $26.6M flat YoY excluding RADx, up 13% QoQ; pro-forma gross margin 35.0% (down 1470 bps YoY, up 670 bps QoQ).","Net loss $35.1M ($0.95/share) vs $15.7M loss a year ago; operating loss $36.6M.","Recorded $8.2M goodwill impairment, $8.7M long-lived asset impairment, $3.4M restructuring costs in Q3.","Business highlights: BioHermes pTau-181 trial nearing completion for FDA clearance; ADDF-funded Alzheimer's plasma test on track."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-115930","json":"https://secwatch.observer/filing/0001104659-22-115930.json","markdown":"https://secwatch.observer/filing/0001104659-22-115930.md","text":"https://secwatch.observer/filing/0001104659-22-115930.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1503274/000110465922115930/0001104659-22-115930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1503274/000110465922115930/tm2229964d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T03:28:19.536435+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"69cc22b75bb218ae76d26cb44f1d59c4ceca00f5","claim":"Quanterix Corp reported financial results for third quarter ended September 30, 2022.","evidence_excerpt":"Quanterix Corporation (“Quanterix”) issued a press release announcing its financial results for the third quarter ended September 30, 2022 (the “Earnings Release”).","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1503274/000110465922115930/0001104659-22-115930-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}